Original Query: ALL
Previous Study | Return to List | Next Study

Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients (CeTeG)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01149109
Recruitment Status : Completed
First Posted : June 23, 2010
Last Update Posted : June 14, 2017
Information provided by (Responsible Party):
Ulrich Herrlinger, University Hospital, Bonn

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : April 6, 2017
  Study Completion Date : April 6, 2017